Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ)

CNY 4.77

(-0.83%)

Market Cap (In CNY)

5.67 Billion

Revenue (In CNY)

2.64 Billion

Net Income (In CNY)

231.86 Million

Avg. Volume

19.98 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.92-5.68
PE
-
EPS
-
Beta Value
0.252
ISIN
CNE1000011G4
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Xue Song Yu
Employee Count
-
Website
https://www.fapharm.com
Ipo Date
2011-03-22
Details
Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells pharmaceutical intermediates, bulk drugs, and formulations in the People's Republic of China. It offers APIs and intermediates, as well as formulations, such as anti-infective, cardiovascular, digestive, leaflet, and other products. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. Fuan Pharmaceutical (Group) Co., Ltd. was founded in 2004 and is headquartered in Chongqing, the People's Republic of China.